Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

MIND-FULNESS-BASED FAMILY RESILIENCE INTERVENTION FOR MOTHERS OF CHILDREN WITH INTELLECTUAL DISABILITIES

sunnuntai 6. syyskuuta 2026 päivittänyt: Filiz ER, Sinop University

STRENGTHENING FAMILY RESILIENCE THROUGH MINDFULNESS: A RANDOMIZED CONTROLLED MIXED-METHODS GROUP INTERVENTION WITH MOTHERS OF CHILDREN WITH INTELLECTUAL DISABILITIES

The goal of this clinical trial is to learn whether an eight-week Mindfulness-Based Family Resilience Group Intervention can improve family resilience and mindfulness in mothers of children with intellectual disabilities. The intervention combines mindfulness practices with principles from Walsh's systemic family resilience model.

The main questions it aims to answer are:

  • Does the intervention improve mothers' reported family resilience?
  • Does the intervention improve mothers' mindfulness?
  • How do mothers describe their caregiving experiences, parenting roles, and family life, and how do these experiences change during the intervention?

Researchers will compare mothers who receive the Mindfulness-Based Family Resilience Group Intervention with mothers in a control group who continue to receive usual care.

Participants in the intervention group will:

  • Attend one group session per week for eight weeks, with each session lasting approximately 90 minutes.
  • Take part in mindfulness practices and activities focused on awareness of thoughts, emotions, and bodily experiences, acceptance, self-compassion, and personal and family resources.
  • Complete assessments of family resilience and mindfulness before the intervention, after the intervention, and at a three-month follow-up.

Participants in the control group will continue to receive usual care and will complete the same assessments at the same time points.

The study will also examine participants' experiences during the group intervention to better understand the processes that accompany changes in family resilience and mindfulness.

Tutkimuksen yleiskatsaus

Tila

Valmis

Ehdot

Interventio / Hoito

Yksityiskohtainen kuvaus

Mothers of children with intellectual disabilities may experience long-term caregiving demands that affect their emotional well-being, coping processes, and family life. Family resilience provides a systemic framework for understanding how families adapt to ongoing challenges by drawing on shared belief systems, organizational resources, communication, and problem-solving processes. Mindfulness, in turn, emphasizes present-moment awareness and a nonjudgmental approach to thoughts, emotions, and bodily experiences. Integrating these two approaches may provide a way to support both individual awareness and family-related coping resources.

The Mindfulness-Based Family Resilience Group Intervention was developed by integrating Walsh's systemic family resilience framework with core mindfulness principles and practices. The program was designed to help mothers become more aware of their thoughts, emotions, and bodily responses; relate to difficult experiences with greater acceptance and self-compassion; recognize automatic patterns of responding; and identify personal and family strengths and resources. Family resilience processes, including meaning-making, organizational patterns, communication, and problem solving, were addressed alongside mindfulness-based experiential practices.

The intervention consisted of eight weekly group sessions, each lasting approximately 90 minutes. Across the program, participants engaged in practices involving breath and body awareness, present-moment attention, nonjudgmental observation of thoughts and emotions, acceptance, self-compassion, emotion regulation, and reflection on personal and family resources. Experiential exercises and group discussions were used to connect mindfulness practices with participants' caregiving experiences, parenting roles, and family relationships.

The study used a randomized controlled, embedded mixed-methods design. The quantitative component was designed to evaluate changes in family resilience and mindfulness over time and to compare these changes between the intervention and usual-care control conditions. The qualitative component was embedded within the intervention process to provide a more detailed understanding of participants' experiences and the processes accompanying change.

Qualitative information obtained from group-session recordings and field notes was examined using thematic analysis. This component focused on how participants described and made sense of their caregiving experiences, difficult thoughts and emotions, parenting roles, personal and family resources, and changes experienced during the intervention. Integrating the quantitative and qualitative components was intended to provide a broader understanding of both changes in the measured outcomes and the experiential processes accompanying those changes.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

32

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Joo

Kuvaus

Inclusion Criteria:

  • * Mothers of children aged 9-17 years.

    • Mothers whose children had mild or moderate intellectual disability.
    • Willingness to participate in the study and provide informed consent.

Exclusion Criteria:

  • Mothers whose children had severe intellectual disability.
  • Not meeting the predefined inclusion criteria.
  • Declining to participate in the study.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Nelinkertaistaa

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Change in Family Resilience and Change in Mindfulness
Participants assigned to the experimental arm received the eight-week Mindfulness-Based Family Resilience Group Intervention. The intervention was delivered once weekly, with each group session lasting approximately 90 minutes. The program integrated Walsh's systemic family resilience framework with mindfulness-based practices, including breath and body awareness, nonjudgmental observation of thoughts and emotions, acceptance, self-compassion, emotion regulation, and activities aimed at identifying personal and family resources.
The Mindfulness-Based Family Resilience Group Intervention was an eight-week, group-based behavioral intervention integrating mindfulness practices with Walsh's systemic family resilience framework. The intervention was delivered once weekly, with each session lasting approximately 90 minutes. The eight sessions focused sequentially on: (1) building safety and awareness, (2) acceptance of emotions and self-compassion, (3) values and meaning-making, (4) acceptance of uncertainty, (5) flexible problem solving, (6) discovering family strengths, (7) consolidating gains and relapse prevention, and (8) integration and closure. Core mindfulness components included breath and body awareness, acceptance-based mindfulness, values-focused mindfulness, cognitive defusion and observing thoughts, strength-focused mindfulness, the three-minute breathing space, and compassion and gratitude meditation. Experiential and group activities were used to support emotional awareness, acceptance, psychological
Ei väliintuloa: Control Group
Participants assigned to the control group continued to receive usual care during the study period and did not receive the Mindfulness-Based Family Resilience Group Intervention. They completed the same outcome assessments as the experimental group at baseline, post-intervention, and the three-month follow-up.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Family Resilience Scale (FRS)
Aikaikkuna: Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Family resilience was assessed using the Family Resilience Scale (FRS), developed by Kaner and Bayraklı (2010). The scale consists of 37 items rated on a 5-point Likert scale ranging from 1 ("Does not describe me at all") to 5 ("Describes me very well"). Total scores range from 37 to 185, with higher scores indicating higher levels of family resilience. The scale includes four subscales: Resilience/Challenge (17 items), Self-Efficacy (9 items), Commitment to Life (8 items), and Control (3 items).
Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Mindful Attention Awareness Scale (MAAS)
Aikaikkuna: Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Mindfulness was assessed using the Mindful Attention Awareness Scale (MAAS), developed by Brown and Ryan (2003). The scale consists of 15 items rated on a 6-point Likert scale ranging from 1 ("Almost always") to 6 ("Almost never"). Total scores range from 15 to 90, with higher scores indicating higher levels of mindful attention and awareness. The Turkish adaptation, validity, and reliability study of the scale was conducted by Özyeşil et al. (2011).
Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Perjantai 13. maaliskuuta 2026

Ensisijainen valmistuminen (Todellinen)

Perjantai 1. toukokuuta 2026

Opintojen valmistuminen (Todellinen)

Tiistai 21. heinäkuuta 2026

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Sunnuntai 6. syyskuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Sunnuntai 6. syyskuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Maanantai 14. syyskuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 14. syyskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Sunnuntai 6. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • 2025/613

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

IPD-suunnitelman kuvaus

Individual participant data will not be made publicly available because of participant confidentiality and privacy considerations. The study included a relatively small sample and qualitative data derived from group-session recordings and field notes, which may increase the risk of participant identification even after de-identification. In addition, specific consent for public sharing of individual participant data was not obtained from participants. Aggregate study findings will be reported in scientific publications.

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .